Alzheimer’s Disease Trials (AD)

---

The following are ongoing Alzheimer’s Disease clinical trials in Canada:

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer’s Disease (COGNITE)

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer’s Disease

A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer’s Disease_ (MissionAD2)

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer’s Disease (AD)

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer’s Disease

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer’s Disease.

A Study of LY3002813 and LY3202626 in Participants With Early Symptomatic Alzheimer’s Disease (TRAILBLAZER-ALZ)

A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer’s Disease

Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer’s Disease (BUENA)